Carl Zeiss buys Laser Diagnostic Technologies for its complementary glaucoma technology
This article was originally published in Clinica
Executive Summary
The US arm of Jena, Germany-based Carl Zeiss Meditec is to expand its glaucoma diagnosis offering through the acquisition of Laser Diagnostic Technologies (LDT), of San Diego, California. Carl Zeiss intends to close the transaction for an undisclosed sum within 30-45 days.